Cardiovascular effects of increasing doses of glycopyrrolate in anesthetized New Zealand white rabbits
American Journal of Veterinary Research · 01.11.2026 · 87 (11)
DOI: 10.2460/ajvr.26.04.0187 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, erschienen am 01.11.2026. Verfasst von Jocelyn J M Marchiori und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada. Hauptthemen laut MEDLINE: Glycopyrrolate, Heart Rate, Blood Pressure. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To characterize the cardiovascular effects of 3 increasing doses of glycopyrrolate in healthy rabbits anesthetized with isoflurane.
Methods
9 healthy 1-year-old female New Zealand white rabbits were anesthetized with isoflurane and received increasing doses of glycopyrrolate at low dose (LD; 0.025 mg/kg), medium dose (MD; 0.05 mg/kg), and high dose (HD; 0.1 mg/kg) IV. Heart rate was recorded at baseline and 3, 5, 10, 20, and 30 minutes after administration of each dose. An arterial blood sample was collected to measure plasma glycopyrrolate concentrations at baseline and 3 and 30 minutes after administration of each dose. Analysis of plasma glycopyrrolate concentrations was performed using LC-MS-MS.
Results
The HD led to a significantly higher heart rate δ value than LD and MD only at 3 minutes (all P < .003). The HD caused significantly higher systolic arterial pressure and mean arterial pressure δ values at 3, 5, 20, and 30 minutes ( P < .05) and diastolic arterial pressure at 3, 20, and 30 minutes ( P < .05) than LD. The MD caused a significantly higher diastolic arterial pressure δ value at 20 and 30 minutes ( P < .05) and mean arterial pressure at 5, 20, and 30 minutes ( P < .05) than LD. The mean plasma concentration that elicited a significant increase in heart rate was 62 ± 16.11 ng/mL.
Conclusions
A brief increase (< 5 minutes) in HR in nonbradycardic rabbits was observed with 0.1 mg/kg of glycopyrrolate during isoflurane anesthesia. Clinical Relevance Even at HDs, clinical effects of glycopyrrolate in rabbits appear very short lived.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada.
- Department of Veterinary Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA.
- Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada.
ORCID-Profile: Hugues Beaufrère, Alexander Valverde
Zitieren
APA
Marchiori, J. J. M., Sanchez, A., Beaufrère, H., Hawker, W., Fonfara, S., Gu, Y., Valverde, A., & Johnson, R. (2026). Cardiovascular effects of increasing doses of glycopyrrolate in anesthetized New Zealand white rabbits. American Journal of Veterinary Research, 87(11). https://doi.org/10.2460/ajvr.26.04.0187
Vancouver
Marchiori JJM, Sanchez A, Beaufrère H, Hawker W, Fonfara S, Gu Y, et al. Cardiovascular effects of increasing doses of glycopyrrolate in anesthetized New Zealand white rabbits. American Journal of Veterinary Research. 2026;87(11). doi:10.2460/ajvr.26.04.0187
BibTeX
@article{Marchiori2026,
author = {Marchiori, Jocelyn J M and Sanchez, Andrea and Beaufrère, Hugues and Hawker, William and Fonfara, Sonja and Gu, Yu and Valverde, Alexander and Johnson, Ron},
title = {Cardiovascular effects of increasing doses of glycopyrrolate in anesthetized New Zealand white rabbits},
journal = {American Journal of Veterinary Research},
year = {2026},
volume = {87},
number = {11},
doi = {10.2460/ajvr.26.04.0187}
}
EUVIMED